Research To Practice Revenue and Competitors

Location

N/A

Total Funding

Publishing

Industry

Estimated Revenue & Valuation

  • Research To Practice's estimated annual revenue is currently $14.4M per year.(i)
  • Research To Practice's estimated revenue per employee is $218,700

Employee Data

  • Research To Practice has 66 Employees.(i)
  • Research To Practice grew their employee count by 20% last year.

Research To Practice's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8M41-5%N/AN/A
#2
$6.2M327%N/AN/A
#3
$9.1M477%N/AN/A
#4
$208.7M68719%N/AN/A
#5
$19.4M8010%N/AN/A
#6
$7.8M408%N/AN/A
#7
$72.4M2711%N/AN/A
#8
$0.1M30%$7MN/A
#9
$7M366%N/AN/A
#10
$11.6M538%N/AN/A
Add Company

What Is Research To Practice?

Research To Practice (RTP) is a Miami-based publisher specializing in cancer education. Our goals are to improve the quality of care received by patients with cancer, and to assist physicians and nurses in the difficult decision-making surrounding cancer treatment. Over the past 25 years, RTP has become one of the most trusted providers of oncology medical education. Founded and led by medical oncologist Neil Love, MD, the RTP team has extensive experience developing educational programs to bridge the gap between research and patient care. RTP currently produces a number of educational activities in various platforms including audio, print, Internet and live meetings, and is comprised of experienced physicians, PhDs, nurses and other oncology scientific professionals. In addition, RTP has an in-house team of writers, designers, publication specialists and meeting planners who execute programs and events nationally each year. Visit http://www.researchtopractice.com to learn more about our group.

keywords:N/A

N/A

Total Funding

66

Number of Employees

$14.4M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.9M66-11%N/A
#2
$16M665%N/A
#3
$21M66N/AN/A
#4
$12.5M6610%N/A
#5
$18.1M6625%N/A